Ultromics joins initiative researching heart failure syndrome

By AuntMinnie.com staff writers

September 30, 2022 -- Ultromics recently joined as a full partner with the Accelerating Medicines Partnership Heart Failure initiative, designed to develop new diagnostic tools for heart failure.

The initiative also includes the U.S. National Institutes of Health and the National Heart Lung and Blood Institute, managed by the Foundation for the National Institutes of Health. The five-year, $37 million collaboration aims to investigate the syndrome of heart failure with preserved ejection fraction (HFpEF).

Ultromics' artificial intelligence tools will be utilized in the research. The company's HFpEF diagnostic algorithm was recently granted breakthrough status from the U.S. Food and Drug Administration for the first HFpEF diagnostic algorithm. Ultromics said this algorithm can detect HFpEF by analyzing the motion of the heart chamber walls from a single echocardiography image.

Copyright © 2022 AuntMinnie.com

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking